Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid- 19
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid- 19
No Thumbnail Available
Publication or External Link
Date
2020-05-07
Authors
Advisor
Citation
Geleris J, Sun Y, Platt J, et al. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine. May 2020. doi:10.1056/nejmoa2012410.
DRUM DOI
Abstract
Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. In this observational study involving patients with Covid-19 who had been admitted to the hospital, hydroxychloroquine administration was not associated with either a greatly lowered or an increased risk of the composite end point of intubation or death. Randomized, controlled trials of hydroxychloroquine in patients with Covid-19 are needed.
Notes
The Supplementary Index contains information including the demographics of the clinical trial. The only races/ ethnicities identified are Non- Hispanic Whites, Non- Hispanic Blacks, and Hispanics.